Ji et al., have demonstrated that SLC7A11 is a key regulator of metabolic reprogramming during NSCLC tumorigenesis and progression and is essential for glucose metabolism, glutamine dependency, and intracellular GSH/GSSG redox balance in NSCLC cells [38]. The gene discussed is SLC7A11; the disease is non-small cell lung carcinoma.